Simon Thomas

Statistics

Publications

Citations

1.6K

H-Index

Active since

2014

Affiliations

University College London(Current)

Autolus (United Kingdom)

CRUK Lung Cancer Centre of Excellence

University College London Hospitals NHS Foundation Trust

Cancer Research UK

Simon Thomas is an author at University College London specializing in immunotherapy, chimeric antigen receptor t-cell therapy, and cancer immunotherapy.

ORCID

Publications per year

2014–2024

Publications

A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy

Brian Philip, Evangelia Kokalaki, Leila Mekkaoui et al. · Blood · 2014 · 401 citations

Life Sciences, Genetics, Molecular Biology +10

CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial

Shaun Cordoba, Shimobi Onuoha, Simon Thomas et al. · Nature Medicine · 2021 · 272 citations · Full text

Medicine, Hematology, Oncology +17

Antitumor activity without on-target off-tumor toxicity of GD2–chimeric antigen receptor T cells in patients with neuroblastoma

Karin Straathof, Barry Flutter, Rebecca Wallace et al. · Science Translational Medicine · 2020 · 205 citations

Life Sciences, Immunology, Oncology +17

An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma

Lydia Lee, Benjamin Draper, Neil Chaplin et al. · Blood · 2017 · 172 citations · Full text

Pharmacy, Molecular Pharmaceutics, Oncology +16

A Rapamycin-Activated Caspase 9-Based Suicide Gene

Maria Stavrou, Brian Philip, Charlotte Traynor-White et al. · Molecular Therapy · 2018 · 94 citations · Full text

Life Sciences, Immunology, Oncology +14

1–5 of 20